Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
type: MedicalStudy
description: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2004-09
end date: 2012-01
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00171912
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Hypereosinophilic Syndrome
study subject: Systemic Mastocytosis
study subject: Chronic Myelomonocytic Leukemia
study subject: Dermatofibrosarcoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Hypereosinophilic Syndrome
keywords: Systemic Mastocytosis
keywords: Chronic Myelomonocytic Leukemia
keywords: Dermatofibrosarcoma

AI Analytics
type: Organization